CVS Health (CVS) AI Stock Analysis

1 Followers

CVS Health

(BX Swiss:CVS)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong Cash GenerationStrong operating and free cash flow gives CVS internal funding for debt service, investment and shareholder returns. The 32% free-cash-flow increase and roughly 80% conversion of net income indicate that the recent earnings recovery is producing meaningful cash, supporting resilience over coming quarters.

Negative Factors

Thin Profit MarginsVery low net and operating margins leave CVS with limited protection against reimbursement pressure, medical-cost increases or unfavorable business mix. Although earnings rebounded sharply, profitability remains below prior stronger periods, making sustained margin recovery important to durable earnings quality.

CVS Health Business Overview & Revenue Model

Company Description

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Hea...

CVS Health Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q3-2026)|Next Earnings Date:Feb 17, 2027

Earnings Call SentimentPositive

The call was strongly positive. CVS Health reported broad-based third-quarter earnings growth, raised 2026 revenue, adjusted EPS, operating income and cash flow guidance, achieved its leverage goal ahead of schedule and expects to resume share repurchases. Management also presented improving Medicare performance, continued pharmacy growth and a favorable longer-term outlook. The principal challenges were elevated medical cost trends, expected 2027 pressure from 340B and lower Caremark membership, and costs associated with the planned separation, but management characterized these items as manageable and described 2027 as a trough year for Health Services.

Positive Updates

Planned Separation into Two Public Companies

CVS Health announced its intention to separate into two independent publicly traded companies: a healthcare solutions company retaining Aetna, Caremark, Pharmacy Services, Specialty Pharmacy, Oak Street and Signify Health, and CVS Pharmacy, comprising retail pharmacy stores, mail order, MinuteClinic and Health 100. The separation is expected to be tax-free for U.S. federal income tax purposes and completed in the first half of 2028, subject to customary conditions.

Negative Updates

Company Guidance

For full-year 2026, CVS Health raised adjusted earnings per share guidance to at least $8.20 from the prior range of $7.90 to $8.10, expects total revenues of at least $420 billion, Health Care Benefits adjusted operating income of at least $5.4 billion, medical benefit ratio in the lower half of our previously discussed range of 89.75% plus or minus 25-basis-points, Pharmacy and Consumer Wellness adjusted operating income of $6.5 billion, and enterprise adjusted operating income of at least $17.05 billion; cash flow from operations is expected to be at least $15.5 billion, more than $5.5 billion above the initial outlook, while 2027 Health Services adjusted operating income is expected to be at least $7 billion, Pharmacy and Consumer Wellness adjusted operating income is expected to grow low single digits off our current 2026 guidance of $6.5 billion, adjusted EPS is expected to be at least $8.65, reflecting approximately 13% growth off an adjusted 2026 baseline, and the company now believes it will be in the high end of our mid-teens adjusted EPS CAGR through 2028.

CVS Health Risk Analysis

CVS Health disclosed 40 risk factors in its most recent earnings report. CVS Health reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

CVS Health Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

CH:CVS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ELV	76Outperform	$92.83B	18.29	11.59%	1.60%	3.60%	-4.06%
CI	75Outperform	$79.88B	13.27	14.10%	2.05%	6.79%	-0.38%
CNC	66Neutral	$34.75B	23.80	6.78%	―	9.71%	―
UNH	62Neutral	$363.00B	23.00	16.35%	2.25%	3.33%	-8.75%
HUM	58Neutral	$52.61B	43.02	6.70%	0.79%	22.02%	-3.07%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

CH:CVS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CNC	Centene	70.48	34.39	95.29%
CI	Cigna	301.45	36.56	13.80%
HUM	Humana	446.31	212.62	90.98%
UNH	Unitedhealth Group Inc.	402.94	79.05	24.40%
ELV	Elevance Health, Inc.	429.48	107.60	33.43%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

CVS Health AI Stock Analysis